v3.26.3
Taxation - Schedule of Deferred Tax Assets (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:      
Temporary difference in accounts receivable recognition $ 5,994 $ 5,815  
Temporary difference in research and development costs 3,086 2,995  
Accrued expense 420 408  
Net operating loss carried forward 13,164 11,961  
Share-based compensation 555 538  
Allowance for credit losses 4,108 4,033  
Total deferred tax assets 27,327 25,750  
Valuation allowance (15,179) (13,803) $ (13,840)
Deferred tax assets, net of valuation allowance $ 12,148 $ 11,947